Connection
Jagar Jasem to Lymphoma, T-Cell, Peripheral
This is a "connection" page, showing publications Jagar Jasem has written about Lymphoma, T-Cell, Peripheral.
|
|
Connection Strength |
|
 |
|
 |
|
0.228 |
|
|
|
-
Haverkos B, Zain J, Kamdar M, Neuwelt A, Davila E, Bradeen X, Major A, Bair S, Jasem J, Smith C, Abbott D, Porcu P. Frontline chemoimmunotherapy with nivolumab and dose-adjusted EPOCH in peripheral T-cell lymphoma: a phase 1 trial. Blood Adv. 2024 02 13; 8(3):708-711.
Score: 0.228